Pure Biologics sp. Revenue and Competitors

Pure Biologics is a biopharmaceutical company focused on early-stage development of drug candidates, diagnostic tools and medical devices with the use of biologicaly active molecules selected in vitro from our proprietary libraries of antibody fragments and aptamers. We developed state-of-the art technological platforms for generation of antibody fragments (PureSelect and PureSelect2 platforms) as well as for selection of chemically modified aptamers (PureApta). Thanks to our expertise and proven track of record in the field of difficult recombinant proteins, as well as thorough biophysical protein analysis available on site we are able to successfuly deliver active proteins and aptamers, molecular targets, a service of protein engineering & analytics and - most importantly - be a reliable, professional partner at the early stage of drug development.